![Thomas Cerny](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Cerny
Präsident bei
Swiss Cancer League
Profil
Thomas Cerny is currently a Director at ProteoMediX AG and TOLREMO therapeutics AG, and the President of Swiss Cancer League.
He was previously a Director at THERAMetrics holding AG from 2009 to 2011.
Prior to his current positions, he was the Head-Oncology at the University of St. Gallen starting in 2009.
He holds a doctorate degree from the University of Bern.
Aktive Positionen von Thomas Cerny
| Unternehmen | Position | Beginn |
|---|---|---|
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 21.06.2010 |
Swiss Cancer League | Präsident | 12.01.2011 |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Direktor/Vorstandsmitglied | - |
Proteomedix AG
 Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Cerny
| Unternehmen | Position | Ende |
|---|---|---|
THERAMetrics holding AG
 THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology Discovers drugs for patients suffering from rare diseases | Direktor/Vorstandsmitglied | 26.05.2011 |
Ausbildung von Thomas Cerny
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology Discovers drugs for patients suffering from rare diseases | Health Technology |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Cancer League | |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Commercial Services |
Wählen Sie MarketScreener 
